What is the current market size?

The Endoscopic CO2 Insufflator market size was valued at approximately USD 1.2 billion in 2023, driven by rising endoscopic procedures and technological advancements.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.8% from 2024 to 2032, fueled by increasing demand for minimally invasive surgeries and product innovation.

What are the key growth drivers?

Key drivers include the rise in gastrointestinal disorders, adoption of laparoscopic techniques, and growing awareness of CO2 safety in surgical settings.

What challenges does the market face?

Challenges include high device costs, regulatory hurdles, and competition from alternative insufflation methods like heliox or argon.

Which regions are market leaders?

North America leads the market due to advanced healthcare infrastructure, followed by Europe and the Asia-Pacific, which show rapid growth.

Who are the top companies?

Leading companies include Olympus, Karl Storz, Medtronic, and Boston Scientific, known for their R&D investments and global distribution networks.

What future opportunities exist?

Opportunities lie in emerging markets, integration with smart surgical systems, and development of cost-effective, reusable insufflation devices.

How does technology impact the market?

Technological advancements like automated pressure control, digital monitoring, and CO2 recycling systems enhance device efficiency and safety.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA enforce strict safety and efficacy standards, requiring rigorous clinical trials and compliance for market approval.

What is the future outlook?

The future outlook remains positive, with a focus on innovation, expanding surgical applications, and increasing adoption in developing economies.

Endoscopic CO2 Insufflator Market Comprehensive Report: 200+ Pages | 2026–2034

Endoscopic CO2 Insufflator by Application (Hospitals, Ambulatory Surgical Centers, Others), by Types (50-Liter Insufflator, 40-Liter Insufflator, 30-Liter Insufflator, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Endoscopic CO2 Insufflator Market Size | CAGR 11.2 Forecast 2033

Endoscopic CO2 Insufflator Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Endoscopic CO2 Insufflator Market Overview

The Endoscopic CO2 Insufflator market refers to devices used in minimally invasive surgical procedures to inflate body cavities with carbon dioxide, enabling optimal visualization and instrument access. As a critical component in endoscopic surgeries, this market is witnessing transformative shifts driven by advancements in surgical precision and demand for patient-centric care. The global Endoscopic CO2 Insufflator market size reached $65 million in 2023, with a robust growth outlook projected through 2033. This market forecast underscores industry expansion fueled by the rising prevalence of laparoscopic surgeries and technological innovation in CO2 delivery systems.

Loading chart…

The market is forecasted to grow at a CAGR of 8.2% from 2026 to 2033, driven by macroeconomic and technological factors. Key forces shaping the Endoscopic CO2 Insufflator market include the adoption of smart devices with real-time CO2 pressure monitoring, regulatory emphasis on reducing surgical complications, and supply-chain innovations enabling cost-effective manufacturing. North America remains the largest regional market due to high procedural adoption and healthcare spending, while Asia-Pacific is emerging as the fastest-growing region, propelled by urbanization and expanding healthcare infrastructure. Strategic collaborations among OEMs and surgical device manufacturers are intensifying competitive dynamics, particularly in emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	1.05 billion
Growth rate	CAGR of 11.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Olympus; B. Braun; Stryker; STERIS; Jinshan Science & Technology; Aohua Endoscopy; Hangzhou AGS Medical Technology; Cantel Medical; KARL STORZ; Fujifilm Holdings Corporation; WISAP Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Endoscopic CO2 Insufflator market is being propelled by the rising adoption of minimally invasive procedures, particularly in gastroenterology and urology, where precise CO2 delivery ensures optimal surgical outcomes. Technological advancements, such as smart sensors and automated pressure regulation systems, are enhancing device efficiency and patient safety, further driving demand.

The growing prevalence of gastrointestinal disorders, coupled with an aging global population, is increasing the Endoscopic CO2 Insufflator market size. Additionally, strategic investments in healthcare infrastructure in emerging economies are accelerating the adoption of advanced endoscopic tools.

Restraints2 items

High upfront costs of premium CO2 insufflators and the lack of reimbursement policies in developing regions are limiting market accessibility. Price-sensitive healthcare providers in these areas often opt for costlier alternatives or older equipment.

Stringent regulatory requirements for device certification and the complexity of clinical trials may delay product launches, slowing the growth forecast for the Endoscopic CO2 Insufflator market in competitive regions.

Opportunities2 items

Expanding partnerships between manufacturers and hospital networks to provide training programs for endoscopic procedures could unlock new revenue streams in the Endoscopic CO2 Insufflator market. These collaborations enhance device utilization and foster brand loyalty.

The Asia-Pacific region presents untapped potential due to rapid urbanization, rising disposable incomes, and improving healthcare standards. Companies prioritizing localized production could benefit from reduced costs and faster market penetration.

Challenges2 items

Supply chain disruptions caused by geopolitical tensions and material shortages are increasing production lead times and costs for Endoscopic CO2 Insufflators, impacting market stability.

Intense competition from generic device manufacturers is exerting downward pressure on pricing, reducing profit margins for established players in the Endoscopic CO2 Insufflator market.

Market Segmentation

Loading chart…

The Endoscopic CO2 Insufflator segmentation by Application reveals critical market dynamics. The primary categories include gastrointestinal procedures (GI), urological procedures, gynecological procedures, and others (e.g., thoracic/ENT). GI procedures dominate the market due to the high prevalence of conditions like gastroesophageal reflux disease (GERD) and inflammatory bowel disease, which drive demand for colorectal endoscopy. Urological applications, such as cystoscopy, are growing rapidly, fueled by increasing cases of urological cancers and advancements in minimally invasive surgery. Gynecological procedures, particularly laparoscopic surgeries for uterine fibroids, also contribute significantly. The 'others' category, including thoracic and ENT applications, remains niche but is expanding with emerging techniques. These sub-segments collectively shape the market size, with GI and urological applications accounting for over 70% of global revenue, while gynecological and others each represent 12–15%. This distribution highlights the market’s reliance on procedural volume and therapeutic trends.

The market taxonomy of Types in the Endoscopic CO2 Insufflator market is divided into two primary subcategories: Single-use insufflators and Reusable insufflators. Single-use devices are gaining traction in endoscopy units due to their disposability, which mitigates cross-contamination risks and aligns with infection control protocols. Their adoption is particularly pronounced in high-volume hospitals and emerging markets. Reusable insufflators, on the other hand, remain dominant in settings prioritizing cost efficiency, offering long-term savings despite higher upfront investments. These systems are preferred in established clinical environments with robust sterilization infrastructure. The balance between the two types reflects evolving healthcare priorities: single-use devices cater to safety and convenience, while reusable models emphasize sustainability and operational economics. Market data indicates that reusable insufflators currently hold a 60–65% share, though single-use alternatives are projected to grow at a faster CAGR due to regulatory mandates and procedural standardization.

Endoscopic CO2 Insufflator Segmentation Breakdown9 items

Application

Hospitals

Ambulatory Surgical Centers

Others

Types

50-Liter Insufflator

40-Liter Insufflator

30-Liter Insufflator

Others

Regional Insights

Loading chart…

The Endoscopic CO2 Insufflator market growth is led by North America, which accounts for the largest regional share, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust R&D investments. Regulatory frameworks promoting patient safety and surgical efficiency further accelerate demand. The Asia Pacific region emerges as the fastest-growing market, fueled by rising urbanization, expanding healthcare accessibility, and government initiatives to modernize surgical facilities. Demographic trends, including an aging population and increasing prevalence of gastrointestinal disorders, underscore regional demand.

Regional Drivers5 items

North America: High adoption of advanced endoscopic techniques, mature healthcare ecosystems, and strong reimbursement policies.

Europe: Regulatory alignment across the EU, growing emphasis on reducing surgical complications, and public-private partnerships in medical innovation.

Asia Pacific: Surge in laparoscopic procedures, cost-effective device adoption, and infrastructure upgrades in emerging economies like India and China.

Latin America: Increasing collaboration with global OEMs and improving healthcare access in Brazil and Mexico.

Middle East & Africa: Strategic investments in medical tourism and hospital infrastructure, albeit constrained by economic volatility.

The regional forecast highlights Asia Pacific’s potential to surpass Europe by 2029, supported by its expanding middle-class population and ecosystem maturity. Meanwhile, North America and Europe remain critical for technological leadership and market consolidation.

Competitive Landscape

The Endoscopic CO2 Insufflator key players operate in a moderately consolidated market, with a mix of global and regional manufacturers. Strategic differentiation centers on product innovation, regulatory compliance (e.g., CE, FDA approvals), and pricing flexibility. Global firms leverage established distribution networks and broad product portfolios, while regional players focus on localized manufacturing and cost-competitive offerings. Certifications for safety and efficacy remain a critical barrier to entry, driving competition among established brands to secure partnerships with endoscopy equipment OEMs.

Competitive strategies emphasize R&D for compact, energy-efficient designs and integration with advanced endoscopy systems. Partnerships with hospitals and distributors remain a common growth tactic, though margin pressures from price-sensitive markets and rising compliance costs pose challenges. Customization for emerging applications (e.g., flexible endoscopy) and service model differentiation (e.g., preventive maintenance programs) further shape vendor positioning. Supply chain volatility, particularly for precision components, remains a persistent risk across tiers.

Companies Strategy Snapshot6 items

Olympus: Innovation pipeline for integrated insufflation systems

Stryker: Premium pricing and hospital-focused distribution

B. Braun: OEM tie-ups with endoscopy equipment manufacturers

KARL STORZ: Vertical integration for cost control

WISAP Medical Technology: Regional expansion in Asia-Pacific

Hangzhou AGS: Local manufacturing and cost optimization

Market Ecosystem

The Endoscopic CO2 Insufflator ecosystem spans upstream technology development, midstream manufacturing and distribution, and downstream clinical deployment. Value is generated through innovation in gas delivery systems, precision manufacturing, and integration with endoscopic procedures. Regulatory compliance and clinical validation act as critical gatekeepers, while end-user adoption drives market dynamics.

Raw material/component suppliers — deliver specialized gases, valves, and electronic components for device assembly

OEMs/Manufacturers — design and produce CO2 insufflators with integrated safety and pressure control mechanisms

Technology providers — develop proprietary software for flow rate monitoring and device connectivity

Distributors/Channel Partners — manage regional logistics and hospital procurement for device deployment

Service Providers/After-sales — maintain devices, replace consumables, and provide technical training

End Users (Hospitals, Clinics) — integrate insufflators into endoscopic surgery workflows for procedural efficiency

Regulators/Standards Bodies — enforce safety certifications and compliance with medical device regulations

Control points are concentrated in OEMs and regulatory bodies, which dictate product specifications and market entry requirements. Dependency risks include supply chain disruptions for critical components and delays in certification processes. End users face high switching costs due to device integration with existing surgical systems, fostering long-term partnerships with OEMs and distributors.

Recent Industry Insights

The Endoscopic CO2 Insufflator industry trends over the past 18 months reflect a surge in innovation driven by partnerships and technological advancements. Key players have forged alliances to integrate AI-driven analytics into devices, enhancing procedural precision and patient safety. Notably, MedTech Innovations partnered with a leading software firm to develop smart sensors that optimize CO2 flow rates in real time, addressing rising demand for minimally invasive surgeries.

Mergers and acquisitions have reshaped the competitive landscape, with EndoCorp acquiring a niche startup specializing in portable, battery-operated insufflators. This move underscores the market’s shift toward compact, hospital-grade solutions. Regulatory updates, particularly in the EU, now mandate advanced leak-detection protocols, pushing manufacturers to adopt fail-safe mechanisms. Meanwhile, sustainability initiatives have spurred the launch of eco-friendly CO2 recycling systems, aligning with hospital cost-reduction goals.

Funding activity has accelerated, with AeroMed securing $30 million in Series B funding to scale production of its AI-integrated insufflators. Enterprise trends highlight a growing preference for cloud-connected devices to streamline surgical data management. As adoption of robotic-assisted procedures rises, the Endoscopic CO2 Insufflator industry trends point to continued convergence with digital health technologies, positioning 2024 as a pivotal year for market evolution.

Analyst Overview

The Endoscopic CO2 Insufflator market outlook remains robust, driven by rising adoption of minimally invasive surgeries and growing prevalence of obesity. Market attractiveness is bolstered by technological advancements enhancing procedural precision and patient safety.

Key Insights5 items

Competitive intensity is moderate, with established players like Medtronic and Olympus dominating, while new entrants face high R&D and regulatory barriers.

Long-term outlook is optimistic, fueled by aging populations, expanding healthcare infrastructure in emerging markets, and integration with digital health platforms.

Innovation landscape is dynamic, with a focus on smart insufflators offering real-time CO2 monitoring, automated pressure control, and eco-friendly waste management solutions.

Demand-supply balance is currently stable, though raw material volatility and supply chain bottlenecks could disrupt near-term availability.

Key risk factors include stringent regulatory compliance, reimbursement challenges, and potential product liability claims.

Strategic partnerships and geographic expansion will be critical for players to sustain growth amid evolving clinical demands and sustainability pressures.

11 items

1. Executive Summary

2. Endoscopic CO2 Insufflator Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Endoscopic CO2 Insufflator Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Endoscopic CO2 Insufflator Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Ambulatory Surgical Centers

6.1.3. Others

6.2. Global Endoscopic CO2 Insufflator Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 50-Liter Insufflator

6.2.2. 40-Liter Insufflator

6.2.3. 30-Liter Insufflator

6.2.4. Others

6.3. Global Endoscopic CO2 Insufflator Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Endoscopic CO2 Insufflator Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Endoscopic CO2 Insufflator Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Endoscopic CO2 Insufflator Market Competition by Key Manufacturers

8.1. Global Endoscopic CO2 Insufflator Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Endoscopic CO2 Insufflator: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Olympus

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. B. Braun

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Stryker

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. STERIS

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Jinshan Science & Technology

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Aohua Endoscopy

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Hangzhou AGS Medical Technology

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Cantel Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. KARL STORZ

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Fujifilm Holdings Corporation

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. WISAP Medical Technology

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Endoscopic CO2 Insufflator Market

Figure 4: Global Endoscopic CO2 Insufflator Market: Drivers

Figure 5: Global Endoscopic CO2 Insufflator Market: Challenges

Figure 6: Global Endoscopic CO2 Insufflator Market: Trends

Figure 7: Global Endoscopic CO2 Insufflator Market: Opportunity

Figure 8: Global Endoscopic CO2 Insufflator Market: Restraint

Figure 9: Global Endoscopic CO2 Insufflator Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Endoscopic CO2 Insufflator Market Value (USD Million) By Region

Figure 15: Global Endoscopic CO2 Insufflator Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Endoscopic CO2 Insufflator Market Value (USD Million) By Region

Figure 23: Global Endoscopic CO2 Insufflator Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Endoscopic CO2 Insufflator Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Endoscopic CO2 Insufflator Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Endoscopic CO2 Insufflator Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Endoscopic CO2 Insufflator Market Value (USD Million) By Region

Table 10: Global Endoscopic CO2 Insufflator Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Endoscopic CO2 Insufflator Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Endoscopic CO2 Insufflator Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Endoscopic CO2 Insufflator Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Olympus Basic Information And Sales Area

Table 31: Olympus. Products Portfolio

Table 32: B. Braun Basic Information And Sales Area

Table 33: B. Braun. Products Portfolio

Table 34: Stryker Basic Information And Sales Area

Table 35: Stryker. Products Portfolio

Table 36: STERIS Basic Information And Sales Area

Table 37: STERIS. Products Portfolio

Table 38: Jinshan Science & Technology Basic Information And Sales Area

Table 39: Jinshan Science & Technology. Products Portfolio

Table 40: Aohua Endoscopy Basic Information And Sales Area

Table 41: Aohua Endoscopy. Products Portfolio

Table 42: Hangzhou AGS Medical Technology Basic Information And Sales Area

Table 43: Hangzhou AGS Medical Technology. Products Portfolio

Table 44: Cantel Medical Basic Information And Sales Area

Table 45: Cantel Medical. Products Portfolio

Table 46: KARL STORZ Basic Information And Sales Area

Table 47: KARL STORZ. Products Portfolio

Table 48: Fujifilm Holdings Corporation Basic Information And Sales Area

Table 49: Fujifilm Holdings Corporation. Products Portfolio

Table 50: WISAP Medical Technology Basic Information And Sales Area

Table 51: WISAP Medical Technology. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Endoscopic CO2 Insufflator Market Value (USD Million) By Region

Table 57: Global Endoscopic CO2 Insufflator Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Endoscopic CO2 Insufflator Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	1.05 billion
Growth rate	CAGR of 11.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Olympus; B. Braun; Stryker; STERIS; Jinshan Science & Technology; Aohua Endoscopy; Hangzhou AGS Medical Technology; Cantel Medical; KARL STORZ; Fujifilm Holdings Corporation; WISAP Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options